Home > Financial Ratios > AAREY DRUGS & PHARMACEUTICALS

AAREY DRUGS & PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for AAREY DRUGS & PHARMACEUTICALS
Please provide your vote to see the results

AAREY DRUGS & PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 11.349.24-25.6820.5517.58

What is the latest Core EBITDA Growth ratio of AAREY DRUGS & PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of AAREY DRUGS & PHARMACEUTICALS is 11.34 based on Mar2025 Standalone results.
Year Core EBITDA Growth
Mar202511.34
Mar20249.24
Mar2023-25.68
Mar202220.55
Mar202117.58

How is Core EBITDA Growth of AAREY DRUGS & PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2025 11.34
22.73
Mar2024 9.24
Positive
Mar2023 -25.68
Negative
Mar2022 20.55
16.89
Mar2021 17.58 -

Other Financial Ratios of AAREY DRUGS & PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of AAREY DRUGS & PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AAREY DRUGS & PHARMACEUTICALS ₹222.9 Cr -4.8% -13.3% 42.1% Stock Analytics
ADANI ENTERPRISES ₹378,650.0 Cr 2.1% 20% 19.1% Stock Analytics
PREMIER ENERGIES ₹47,789.8 Cr 7% 1.4% 2% Stock Analytics
ADITYA INFOTECH ₹36,901.9 Cr 22.4% 34.2% NA Stock Analytics
AEGIS LOGISTICS ₹27,184.9 Cr 5.9% 9.3% -7.2% Stock Analytics
REDINGTON ₹18,227.1 Cr 4% 8.8% -15.7% Stock Analytics


AAREY DRUGS & PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AAREY DRUGS & PHARMACEUTICALS

-4.8%

-13.3%

42.1%

SENSEX

-1.5%

-3.4%

-9.1%


You may also like the below Video Courses